A5076804422- Inflammatory Bowel Disease
- Microscopic Colitis
- Liver Diseases and Immunity
- Liver Disease Diagnosis and Treatment
- Helicobacter pylori-related gastroenterology studies
- Liver Disease and Transplantation
- Eosinophilic Esophagitis
- Hepatitis Viruses Studies and Epidemiology
- Biosimilars and Bioanalytical Methods
- Gastric Cancer Management and Outcomes
- Hepatitis C virus research
- Biliary and Gastrointestinal Fistulas
- Gastrointestinal disorders and treatments
- Diet, Metabolism, and Disease
- Gastroesophageal reflux and treatments
- Diverticular Disease and Complications
Polydoro Ernani de São Thiago University Hospital
2022-2025
Universidade Federal de Santa Catarina
2021-2022
Universidade Federal do Paraná
2010
Seoul National University Hospital
2010
University Gastroenterology
2010
Abstract Background Biological therapy has revolutionized the treatment of inflammatory bowel disease (IBD); however, a subset patients still requires optimization to achieve therapeutic goals. This study aimed identify who underwent biological (TO) and compare their characteristics with those did not require such adjustments. Methods A retrospective was conducted using data from national patient registry GEDIIB (Brazilian Crohn's Colitis Organization). total 1,660 (CD) 530 ulcerative...
Liver cirrhosis is often complicated by an immunological imbalance known as cirrhosis-associated immune dysfunction. This study aimed to investigate disturbances in circulating monocytes and dendritic cells patients with acute decompensation (AD) of cirrhosis. The sample included 39 adult cirrhotic hospitalized for AD, 29 stable (SC), 30 healthy controls (CTR). Flow cytometry was used analyze monocyte cell subsets whole blood quantify cytokines plasma samples. Cirrhotic groups showed higher...
RACIONAL: As medicações mais frequentemente prescritas e usadas de forma crônica por pacientes com queixas dispépticas pertencem ao grupo dos inibidores bomba prótons cujo principal representante é o omeprazol, utilizado clinicamente a cerca 20 anos. Estudos recentes têm postulado relação entre uso crônico desta medicação alterações proliferativas macroscópicas microscópicas da mucosa do fundo corpo gástrico, principalmente os pólipos glândulas fúndicas. OBJETIVO: Analisar frequência tipo...
Abstract Background Anti-TNF therapy represented a landmark in medical treatment of ulcerative colitis (UC). There is lack data on the efficacy and safety these agents Brazilian patients. The present study aimed to analyze rates clinical endoscopic remission comparatively, between adalimumab (ADA) infliximab (IFX), patients with UC, evaluate factors associated after 1 year treatment. Methods A national retrospective multicenter (24 centers) was performed including UC treated anti-TNF...
Abstract Background Anti-TNF therapy represented a landmark in medical treatment of ulcerative colitis (UC). There is lack data on the efficacy and safety these agents Brazilian patients, as public reimbursement relatively recent. The present study aimed to analyze rates clinical endoscopic remission comparatively, between adalimumab (ADA) infliximab (IFX), UC evaluate possible factors associated with after 1 year treatment. Methods A national retrospective multicenter (24 centers) was...